Crinetics Pharmaceuticals Inc (CRNX)

$34.10 +0.33 (0.98%)
Market Cap 3.20B
Revenue (ttm) 1.04M
Net Income (ttm) -298.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28,693.27%
Debt to Equity Ratio 0.00
Volume 583,120
Avg Vol 1,010,192
Day's Range N/A - N/A
Shares Out 94.18M
Stochastic %K 17%
Beta 0.28
Analysts Strong Sell
Price Target $69.62

Company Profile

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in a Phase 3 clinical trial for the treatment of acromegaly and carcinoid syndrome associated with neuroendocrine tumors. It is also developing Atumelnant,...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 450 6464
Address:
6055 Lusk Boulevard, San Diego, United States
highnihilism
highnihilism Sep. 16 at 6:17 PM
IWM: Russell 2000 → $PTCT PTC Therapeutics $PRCH Porch Group $SMLR Semler Scientific $BBBY Bed Bath & Beyond $CRNX Crinetics Pharmaceuticals
0 · Reply
highnihilism
highnihilism Sep. 16 at 2:50 PM
Biotech → $CRNX Crinetics Pharmaceuticals $IONS Ionis Pharmaceuticals $PTCT PTC Therapeutics $RARE Ultragenyx Pharmaceutical $MDGL Madrigal Pharmaceuticals
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 16 at 2:03 PM
$CRNX If they will not declare in the pre market even if it is good news we re screwed
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 16 at 12:37 PM
$CRNX Damn you big whales
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 16 at 12:22 PM
$CRNX JESUS
0 · Reply
phildeeze
phildeeze Sep. 15 at 2:56 PM
$CRNX
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 15 at 2:38 PM
$CRNX OMG LAST TEN DAY THERE IS NO RISE AT ALL
1 · Reply
killbilltrader
killbilltrader Sep. 15 at 2:36 PM
$CRNX what is the upside with an approval.? They got a good pipeline and a data readout before the EOY.
1 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 13 at 7:17 AM
$CRNX
0 · Reply
Cmhatwell
Cmhatwell Sep. 12 at 6:35 PM
$CRNX since aug 1 seeing higher highs and higher lows
0 · Reply
Latest News on CRNX
Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 10, 2025, 4:30 PM EDT - 5 days ago

Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)

Aug 21, 2025, 8:45 AM EDT - 26 days ago

Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 11, 2025, 4:05 PM EDT - 5 weeks ago

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 11:21 AM EDT - 5 weeks ago

Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call Transcript

Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 7, 2025, 4:05 PM EDT - 5 weeks ago

Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025

Jul 13, 2025, 5:45 PM EDT - 2 months ago

Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025

Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 11, 2025, 8:00 AM EDT - 2 months ago

Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 10, 2025, 4:28 PM EDT - 2 months ago

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline

Jun 30, 2025, 4:05 PM EDT - 2 months ago

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025

Jun 16, 2025, 8:00 AM EDT - 3 months ago

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 10, 2025, 4:29 PM EDT - 3 months ago

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

May 23, 2025, 8:00 AM EDT - 4 months ago

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025

May 15, 2025, 4:05 PM EDT - 4 months ago

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025

Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 12, 2025, 4:05 PM EDT - 4 months ago

Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals, Inc (CRNX) Q1 2025 Earnings Call Transcript

May 10, 2025, 1:50 PM EDT - 4 months ago

Crinetics Pharmaceuticals, Inc (CRNX) Q1 2025 Earnings Call Transcript

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

May 8, 2025, 4:05 PM EDT - 4 months ago

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 11, 2025, 8:00 AM EDT - 5 months ago

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 10, 2025, 5:04 PM EDT - 5 months ago

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharma: Strong Progress With Multiple Indications And Upcoming PDUFA

Apr 2, 2025, 2:15 PM EDT - 5 months ago

Crinetics Pharma: Strong Progress With Multiple Indications And Upcoming PDUFA

Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly

Mar 27, 2025, 4:05 PM EDT - 6 months ago

Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly

Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 10, 2025, 4:36 PM EDT - 6 months ago

Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals, Inc (CRNX) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 1:01 PM EST - 7 months ago

Crinetics Pharmaceuticals, Inc (CRNX) Q4 2024 Earnings Call Transcript

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 27, 2025, 4:05 PM EST - 7 months ago

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer

Feb 24, 2025, 8:30 AM EST - 7 months ago

Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences

Feb 20, 2025, 4:05 PM EST - 7 months ago

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences

Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 10, 2025, 4:44 PM EST - 7 months ago

Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Feb 6, 2025, 4:35 PM EST - 7 months ago

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 10, 2025, 5:15 PM EST - 8 months ago

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Jan 10, 2025, 7:00 AM EST - 8 months ago

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 8:00 AM EST - 9 months ago

Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness

Jan 2, 2025, 5:53 AM EST - 9 months ago

Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness

Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 10, 2024, 8:44 PM EST - 9 months ago

Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

Dec 9, 2024, 8:00 AM EST - 10 months ago

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

Nov 14, 2024, 4:05 PM EST - 10 months ago

UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:00 PM EST - 10 months ago

Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript

Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

Nov 12, 2024, 4:07 PM EST - 10 months ago

Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024, 4:05 PM EST - 10 months ago

Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nov 11, 2024, 4:05 PM EST - 11 months ago

Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 10, 2024, 4:40 PM EDT - 1 year ago

Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Oct 8, 2024, 11:55 PM EDT - 1 year ago

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Oct 8, 2024, 4:01 PM EDT - 1 year ago

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

Sep 26, 2024, 4:05 PM EDT - 1 year ago

Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 10, 2024, 4:40 PM EDT - 1 year ago

Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 9:23 PM EDT - 1 year ago

Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2024 Earnings Call Transcript

Crinetics Launches ACRO/TRUTH Educational Initiative to Raise Awareness of Acromegaly Treatment Challenges

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Crinetics Launches ACRO/TRUTH Educational Initiative to Raise Awareness of Acromegaly Treatment Challenges

Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

Jul 18, 2024, 4:05 PM EDT - 1 year ago

Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024

Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 10, 2024, 7:29 PM EDT - 1 year ago

Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner

Jun 18, 2024, 4:30 PM EDT - 1 year ago

EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner

highnihilism
highnihilism Sep. 16 at 6:17 PM
IWM: Russell 2000 → $PTCT PTC Therapeutics $PRCH Porch Group $SMLR Semler Scientific $BBBY Bed Bath & Beyond $CRNX Crinetics Pharmaceuticals
0 · Reply
highnihilism
highnihilism Sep. 16 at 2:50 PM
Biotech → $CRNX Crinetics Pharmaceuticals $IONS Ionis Pharmaceuticals $PTCT PTC Therapeutics $RARE Ultragenyx Pharmaceutical $MDGL Madrigal Pharmaceuticals
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 16 at 2:03 PM
$CRNX If they will not declare in the pre market even if it is good news we re screwed
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 16 at 12:37 PM
$CRNX Damn you big whales
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 16 at 12:22 PM
$CRNX JESUS
0 · Reply
phildeeze
phildeeze Sep. 15 at 2:56 PM
$CRNX
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 15 at 2:38 PM
$CRNX OMG LAST TEN DAY THERE IS NO RISE AT ALL
1 · Reply
killbilltrader
killbilltrader Sep. 15 at 2:36 PM
$CRNX what is the upside with an approval.? They got a good pipeline and a data readout before the EOY.
1 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 13 at 7:17 AM
$CRNX
0 · Reply
Cmhatwell
Cmhatwell Sep. 12 at 6:35 PM
$CRNX since aug 1 seeing higher highs and higher lows
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 12 at 5:16 PM
$CRNX enough is ….. enouhj short term traders why you are doing this price is still cheap 1-2$ Fussy Palsitoline will wipe out the acromegaly from the face of the earth enough it s time to rise
1 · Reply
repeatwealth
repeatwealth Sep. 12 at 4:39 PM
$CRNX Where we see this going on/after 9/25 for their PDUFA decision?
1 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 12 at 2:38 PM
$CRNX FOR GOD SAKE WHYYYYYYYY ONE STEP FORWARD THEN AGAIN WHERE IT IS WE NEED VOLATILITY
0 · Reply
CH_Expat
CH_Expat Sep. 12 at 1:36 PM
$CRNX Debatable. I expect an early aporoval. And I would not be surprised about a fake sell the news event.
0 · Reply
jdp07606
jdp07606 Sep. 12 at 10:54 AM
$CRNX not happy with this week at all. Should have kept building. Why did insiders sell early September?
0 · Reply
Oscarca
Oscarca Sep. 12 at 8:13 AM
$CRNX
0 · Reply
Cmhatwell
Cmhatwell Sep. 11 at 5:39 PM
$CRNX
0 · Reply
CDMO
CDMO Sep. 11 at 5:09 PM
$CRNX averaged up
0 · Reply
jdp07606
jdp07606 Sep. 11 at 4:08 PM
$CRNX something bad coming.
1 · Reply
Walleyeslayer
Walleyeslayer Sep. 11 at 1:45 PM
$CRNX This one will make us happy at some point. Will be watching for a good entry.
0 · Reply
FITTEST_RETAIL_TRADER
FITTEST_RETAIL_TRADER Sep. 10 at 8:52 PM
$CRNX BUY MORE MORE THIS IS ONE LAST OPPORTUNITY
0 · Reply
jdp07606
jdp07606 Sep. 10 at 7:22 PM
$CRNX why is stock down with all the good news ?
5 · Reply